Literatur
-
1 American Psychiatric Association .Diagnostic and Statistical Manual of Mental Disorders. 3rd revised ed. (DSM-III-R). Washington DC; APA 1987
-
2 Barkley R A. ADHD and the nature of self-control. New York; The Guilford Press 1997
-
3
Wood D R, Reimherr F W, Wender P H, Johnson G E.
Diagnosis and treatment of minimal brain dysfunction in adults.
Arch Gen Psychiatry.
1976;
33
1453-1460
-
4 Wender P H. Minimal Brain Dysfunction in Children. New York; Wiley 1971
-
5
Barkley R A.
Behavioral inhibition, working memory, sustained attention and executive functions: constructing a unifying theory of ADHD.
Psychol Bull.
1997;
12
65-94
-
6 American Psychiatric Association .Diagnostic and Statistical Manual of Mental Disorders. 4th ed., Text Revision (DSM-IV-TR). Washington DC; APA 2000
-
7 World Health Organisation .Tenth Revision of the International Classification of Diseases and Related Health Problems (ICD-10). Geneva; WHO 1992
-
8
Swanson J M.
Compliance with stimulants for attention-deficit/hyperactivity disorder. Issues and approaches for improvement.
ZNS Drugs.
2003;
17
117-131
-
9
Biederman J, Faraone S, Milberger S. et al .
Results from a four-year prospective follow-up study.
J Am Acad Child Adolesc Psychiatry.
1996;
35
343-351
-
10
Faraone S V, Sergeant J, Gilberg C, Biederman J.
The worldwide prevalence of ADHD: Is it an American condition?.
World Psychiatry.
2003;
2
104-113
-
11
Preuss U, Ralston S J, Baldursson G. et al .
Study design, baseline patient characteristics and intervention in a cross-cultural framework: results from the ADORE study.
Eur Child Adolesc Psychiatry.
2006;
15
i4-i14
-
12
Cox D J, Merkel R L, Davatchev B. et al .
Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder: A preliminary double-blind placebo controlled trial.
J Nerve Ment.
Dis;
188
230-234
-
13
Cox D, Merkel R, Lawrence R. et al .
Impact of methylphenidate delivery profiles on driving performance of adolescents with attention-deficit/hyperactivity disorder: a pilot study.
Journal of the American Academy of Child & Adolescent Psychiatry.
2004;
43
269-275
-
14
Barbaresi W J, Katusic S K, Colligan R C. et al .
How common is attention-deficit/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, Minn.
Arch Pediatr Adolesc Med.
2002;
156
217-224
-
15
Wilens T E, Biederman J, Spencer T J.
Attention deficit/hyperactivity disorder across the lifespan.
Annu Rev Med.
2002;
53
112-131
-
16
Biederman J, Faraone S, Spencer T. et al .
Patterns of psychiatric co-morbidity cognition and psychosocial functioning in adults with attention deficit hyperactivity disorder.
Am J Psychiatry.
1993;
150
1792-1798
-
17
Krause K H, Dresel S H, Krause J. et al .
Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography.
Neurosci Lett.
2000;
285
107-110
-
18
Zametkin A J, Liotta W.
The neurobiology of attention-deficit/hyperactivity disorder.
J Clin Psychiatry.
1998;
59
17-23
-
19
Bush G. et al .
Anterior cingulated cortex dysfunction in attention-deficit/Hyperactivity disorder by fMRI and Counting Stroop.
Biol Psychiatry.
1999;
57
1542-1552
-
20
Cardinal R N, Pennicott D R, Sugathapala C L. et al .
Impulsive choice induced in rats by lesions of the nucleus accumbens core.
Science.
2001;
292
2499-2501
-
21
Dinn W M, Robbins N C, Harris C L.
Adult attention deficit-disorder/hyperactivity disorder: neuropsychological correlates and clinical presentation.
Brain Cogn.
2001;
46
114-121
-
22
Teicher M H, Anderson C M, Polcari A. et al .
Functional deficits in basal ganglia of children with attention-deficit/hyperactivity disorder shown in functional magnetic resonance imaging relaxometry.
Nat Med.
2000;
6
470-416
-
23
Sauver J LS, Barbaresi W J, Katusic S K. et al .
Early life risk factors for attention-deficit/hyperactivity disorder: a population-based cohort study.
Mayo Clin Proc.
2004;
79
1124-1131
-
24 Conners C K. Conners' Rating Scales - Revised CRS-R. North Tonawanda; MHS 1997
-
25
Swanson J M, Wigal S B, Udrea D. et al .
Evaluation of individual subjects in the analog classroom setting: I Examples of graphical and statistical procedures for within-subject ranking of responses to different delivery patterns of methylphenidate.
Psychopharmacol Bull.
1998;
34
825-832
-
26 DuPaul G J, Power T J, Anastopoulus A D, Reid R. ADHD Rating Scale-IV. Checklists, Norms, and Clinical Interpretation. London; Guilford Press 1998
-
27
Retz-Junginger P, Retz W, Blocher D. et al .
Reliabilität und Validität der Wender-Utah-Rating-Scale-Kurzform.
Nervenarzt.
2003;
74
987-993
-
28 Wender P H. Attention Deficit-/Hyperactivity Disorder in Adults. New York; Oxford 1995
-
29 Conners C K, Erhardt D, Sparrow E. Conners' Adult ADHD Rating Scales (CAARS). North Tonawanda, NY; Multi-Health Systems 1999
-
30
Rösler M, Retz W, Retz-Junginger P. et al .
Instrumente zur Diagnostik der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) im Erwachsenenalter: Selbstbeurteilungsskala (ADHS-SB) und Diagnose Checkliste (ADHS-DC).
Nervenarzt.
2004;
75
888-895
-
31
Linnet K M, Dalsgaard S, Obel C. et al .
Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence.
Am J Psychiatry.
2003;
160
1028-1040
-
32
Bussing R, Zima B T, Gary F A. et al .
Social networks, caregiver strain, and utilization of mental health services among elementary school students at high risk for ADHD.
J Am Acad Child Adolesc Psychiatry.
2003;
42
842-850
-
33 Deutsche Gesellschaft für Kinder- und Jugendpsychiatrie u. a. (Hrsg) .Leitlinien zur Diagnostik und Therapie von psychischen Störungen im Säuglings-, Kindes- und Jugendalter. 2. überarbeitete Auflage. Köln; Deutscher Ärzte Verlag 2003
-
34
Krause E D, Roth-Sackenheim J.
ADHS im Erwachsenenalter - Leitlinien auf der Basis eines Expertenkonsensus mit Unterstützung der DGPPN.
Der Nervenarzt.
2003;
10
939-946
-
35
Faraone S V, Tsuang M T.
Adult attention deficit hyperactivity disorder.
Current Psychiatry Reports.
2001;
3
29-130
-
36 Green M, Wong M, Atkins D. et al .Diagnosis of Attention Deficit/Hyperactivity Disorder. Technical Review. No. 3. Tockville, MD; Agency for Health Care Policy and Research 1999
-
37
MTA Cooperative Group .
A 14-month randomized clinical trial of treatment strategies for attention deficit/hyperactivity disorder.
Arch Gen Psychiatry.
1999;
56
1073-1086
-
38 Angold A, Costello E J. The epidemiology of disorders of conduct: nosological issues and comorbidity. In: Hill J, Maughan B, Goodyer IM (eds) Conduct Disorders in Childhood and Adolescence. Cambridge; Cambridge University Press 2000: 126-168
-
39
Biederman J, Faraone S V, Keenan K. et al .
Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder: patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples.
Arch Gen Psychiatry.
1992;
49
728-738
-
40
Mannuzza S, Klein R G.
Long-term prognosis in attention-deficit/hyperactivity disorder.
Child Adolesc Psychiatr Clin N Am.
2000;
9
711-726
-
41
Biederman J.
Pharmacotherapy for ADHD.
J Clin Psychiatry.
2003;
64
3-8
-
42
Szatmari P, Boyle M, Gifford D R.
ADHD and conduct disorder: Degree of adequate overlap and differences among correlates.
J Am Acad Child Adolesc Psychiatry.
1989;
28
865-872
-
43
Bird H R, Gould M, Staghezza B.
Patterns of diagnostic comorbidity in a community sample of children ages 9 through 16 years.
J Am Acad Child Adolesc Psychiatry.
2003;
32
361-368
-
44
Pliszka S.
Effect of anxiety on cognition, behavior and stimulant response in ADHD.
J Am Acad Child Adolesc Psychiatry.
1989;
28
882-887
-
45
Biederman J, Newcorn J, Sprich S.
Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders.
Am J Psychiatry.
1991;
148
564-577
-
46
Geller B, Luby J.
Child and adolescent bipolar disorder: a review of the past 10 years.
J Am Child Adolesc Psychiatry.
1997;
36
1168-1176
-
47
Cohen D J, Leckman J F.
Developmental psychopathology and neurobiology of Tourette's syndrome.
J Am Acad Child Adolesc Psychiatry.
1994;
33
2-15
-
48
Remschmidt H.
Was sind Teilleistungsschwächen?.
Monatszeitschr Kinderheilk.
1987;
135
290-296
-
49
Pliszka S R.
Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder.
Child Adolesc Psychiatr Clin N Am.
2000;
9
525-540
-
50
Duel B P, Steinberg-Epstein R, Hill M, Lerner M.
A survey of voiding dysfunction in children with attention deficit-hyperactivity disorder.
J Urol.
2003;
170
1521-1523
-
51
Corkum P, Tannock R, Moldofsky H.
Sleep disturbances in children with attention-deficit/hyperactivity disorder.
J Am Acad Child Adolesc Psychiatry.
1998;
37
637-646
-
52
Gottlieb D J, Vezina R M, Chase C. et al .
Symptoms of sleep-disordered breathing in 5-year-old children are associated with sleepiness and problem behaviors.
Pediatrics.
2003;
112
870-877
-
53
Dunn D W, Austin J K, Harezlak J, Ambrosius W T.
ADHD and epilepsy in childhood.
Dev Med Child Neurol.
2003;
45
50-54
-
54
Holtmann M, Becker K, Kentner-Figura B, Schmidt M H.
Increased frequency of rolandic spikes in ADHD-children.
Epilepsia.
2003;
44
1241-1244
-
55
Ishii T. et al .
Comorbidity in attention deficit-hyperactivity disorder.
Psychiatry and Clinical Neurosciences.
2003;
57
457-463
-
56
Dale C. et al .
ADHD as a Risk Factor for incident unprovoked seizures and epilepsy in children.
Arch Gen Psychiatry.
2004;
61
731-736
-
57
Fischer M, Barkley R A, Smallish L, Fletcher K.
Young adult follow-up of hyperactive children: self-reported psychiatric disorders, comorbidity, and the role of childhood conduct problems and teen CD.
J Abnorm Child Psychol.
2002;
30
463-475
-
58
Wazana A.
Are there injury-prone children? A critical review of the literature.
Can J Psychiatry.
1997;
42
602-610
-
59
Biederman J, Faraone S V, Spencer T. et al .
Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder.
Am J Psychiatry.
1993;
150
1792-1798
-
60 Reiff M I, Tippins S. ADHS: A Complete and Authoritative Guide. Elk Grove Village, IIl; American Academy of Pediatrics 2004
-
61 2003 InfoPOEM. Key word: attention deficit hyperactivity disorder. (Accessed December 17, 2004, at http://www.infopoems.com).
-
62
Wilens T, Biederman J, Spencer T.
Pharmacotherapy of attention-deficit/hyperactivity disorder in adults.
CNS Drugs.
1998;
9
347-356
-
63 Jadad A R, Boyle M, Cunningham C. et al .Treatment of attention deficit/hyperactivity disorder. Evidence report/technology assessment. No. 11. Rockville, Md; Agency for Healthcare Research and Quality 1999
-
64
Cooperative Group .
MTA National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-months outcomes of treatment strategies for attention-deficit/hyperactivity disorder.
Pediatrics.
2004;
113
754-761
-
65
Efron D, Jarman F, Barker M.
Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial.
Pediatrics.
1997;
100
662-666
-
66
Efron D, Jarman F, Barker M.
Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trail.
Pediatrics.
1997;
100
E6
-
67
American Academy of Pediatrics, Subcommittee on Attention-Deficit/Hyperactivity Disorder and Committee on Quality Improvement .
Clinical practice guideline: treatment of the school-age child with attention-deficit/hyperactivity disorder.
Pediatrics.
2001;
108
1033-1044
-
68
Greenhill L L, Pliszka S, Dulcan M K. et al .
Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.
J Am Acad Child Adolesc Psychiatry.
2002;
41, Suppl
26S-49S
-
69
Cherland E, Fitzpatrick R.
Psychotic side effects of psychostimulants: a 5-year review.
Can J Psychiatry.
1999;
44
811-813
-
70
Surles L K, May H J, Garry J P.
Adderall-induced psychosis in an adolescent.
J Am Board Fam Pract.
2002;
15
498-500
-
71
Tossell J W, Greenstein D K, Davidson A L. et al .
Stimulant drug treatment in childhood-onset schizophrenia with comorbid ADHD: an open-label case series.
J Child Adolesc Psychopharmacol.
2004;
14
448-454
-
72
Barkley R A, McMurray M B, Edelbrock C S, Robbins K.
Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation.
Pediatrics.
1990;
86
184-192
-
73
O'Brien L M, Ivanenko A, Crabtree V M. et al .
The effect of stimulants on sleep characteristics in children with attention deficit/hyperactivity disorder.
Sleep Med.
2003;
4
309-316
-
74
National Institute of Mental Health .
National Institute of Mental Health. Multimodal treatment study of ADHD follow-up: changes in effectiveness and growth after the end of treatment.
Pediatrics.
2004;
113
762-769
-
75
Nissen S E.
ADHD drugs and cardiovascular risk.
N Engl J Med.
354;
14
1445-1448
-
76
Hämmerli M, Mühlebach S.
Ist der Einsatz von Methylphenidat mit einem kardiovaskulären Risiko verbunden?.
Paediatrica.
2002;
13
30-33
-
77
Gracious B L.
Atrioventricular nodal re-entrant tachycardia associated with stimulant treatment.
J Child Adolesc Psychpharmacol.
1999;
9
125-128
-
78
Kelsey D K, Summer C R, Casat C D. et al .
Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behaviour: a double-blind, placebo-controlled trial.
Pediatrics.
2004;
114
e1-e8
-
79
Spencer T, Heiligenstein J H, Biederman J. et al .
Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder.
J Clin Psychiatry.
2002;
63
1140-1147
-
80
Abboud L.
Lilly warns doctors about Strattera.
Wall Street Journal.
December 20, 2004;
B4
-
81 Product information. Strattera (Atomoxetine). Indianapolis; Eli Lilly 2004
-
82
Kratochvil C J, Heiligenstein J H, Dittmann R. et al .
Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.
J Am Acad Child Adolesc Psychiatry.
2002;
41
776-784
-
83
Michelson D, Buitelaar J K, Danckaerts M. et al .
Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study.
J Am Acad Child Adolesc Psychiatry.
2004;
43
896-904
-
84
Sawant S, Daviss S R.
Seizures and prolonged QTc with atomoxetine overdose.
Am J Psychiatry.
2004;
161
757
-
85
Lee T S, Lee T D, Lombroso P J, King R A.
Atomoxetine and tics in ADHD.
J Am Acad Child Adolesc Psychiatry.
2004;
43
1068-1069
-
86
Ratner S, Laor N, Bronstein Y. et al .
Six-week open-label reboxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder.
J Am Acad Child Adolesc Psychiatry.
2005;
44
428-433
-
87
Barrickman L L, Perry P J, Allen A J. et al .
Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder.
J Am Acad Child Adolesc Psychiatry.
1995;
34
649-657
-
88
Conners C K, Casat C D, Gualtieri C T. et al .
Bupropion hydrochloride in attention deficit disorder with hyperactivity.
J Am Acad Child Adolesc Psychiatry.
1996;
35
1314-1321
-
89
Pine D S, Klein R G, Lindy D C, Marshall R D.
Attention-deficit hyperactivity disorder and comorbid psychosis: a review and two clinical presentations.
J Clin Psychiatry.
1993;
54
140-145
-
90
Gunther T, Herpertz-Dahlmann B, Jolles J, Konrad K.
The influence of risperidone on attentional functions in children and adolescents with attention-deficit/hyperactivity disorder and co-morbid disruptive behavior disorder.
J Child Adolesc Psychopharmacol.
2006;
16
725-735
-
91
Faraone S V, Spencer T, Aleardi M. et al .
Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder.
Journal of Clinical Psychopharmacology.
2004;
24
24-29
-
92 Fritze J, Schmauß M. Off-Label-Use: Der Fall Methylphenidat für den Vorstand der Deutschen Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN) 2002. http://www.dgppn.de/stellungnahmen/2003/pdf/Off-Label-Use-Methylphenidat.pdf letzter Zugriff 14.11.2004
-
93
Biederman J, Wilens T E, Mick E. et al .
Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence?.
Biol Psychiatry.
1998;
44
269-273
-
94
Krause K H, Dresel S H, Krause J. et al .
The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder.
Neurosci Biobehav Rev.
2003;
27
605-613
-
95
Krause J, Fougere C la, Krause K H. et al .
Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD.
Eur Arch Psychiatry Clin Neurosci.
2005;
225
428-431
-
96
Abikoff H, Hechtman L, Klein R G. et al .
Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment.
J Am Acad Child Adolesc Psychiatry.
2004;
43
802-811
-
97
M W eiss, Hechtman L, Weiss G.
ADHD in Parents.
J Am Acad Child Adolesc Psychiatry.
2000;
39
1059-1061
-
98 Lauth W, Schlottke P F. Training mit aufmerksamkeitsgestörten Kindern. Materialien für die klinische Praxis/Praxismaterial. 5 vollständig überab. Auflage. Weinheim; Psychologie Verlagsunion 2002
-
99
Preuss U, Freisberg R, Marx H, Bach N.
Ein Heim für „wilde Kinder”.
Unsere Jugend.
2007;
1
23-32
-
100
Bach N, Freisberg R, Preuss U.
Die stationäre Behandlung von Kindern mit ADHS in Wohngruppen der Jugendhilfe.
Forum der Kinder- und Jugendpsychiatrie und Psychotherapie.
2005;
15
76-88
-
101
Wolraich M L, Wilson D B, White J W.
The effect of sugar on behavior or cognition in children: a meta-analysis.
JAMA.
1995;
274
1617-1621
-
102
Voigt R G, Llorente A M, Jensen C L. et al .
A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder.
J Pediatr.
2001;
139
189-196
-
103
Wolraich M L.
Addressing behavior problems among school-aged children: traditional and controversial approaches.
Pediatr Rev.
1997;
18
266-270
-
104
Klein R G, Mannuzza S.
Long-term outcome of hyperactive children: a review.
J Am Acad Child Adolesc Psychiatry.
1991;
30
383-387
-
105
Mannuzza S, Klein R G, Bessler A. et al .
Adult psychiatric status of hyperactive boys grown up.
Am J Psychiatry.
1998;
155
493-498
-
106 Weiss G, Hechtman L. Hyperactive children grown up. New York; Guilford Press 1986
-
107 Preuss U, Rothenberger A, Vlasveld L. et al .Two-year paneuropean observational study of ADHS: Overview and baseline. Lecture hold at the APA congress,. Atlanta GA USA; 2005
Dr. Dr. Ulrich Preuss
Universitätsklinik für Kinder- und Jugendpsychiatrie Psychotherapie
Effingerstraße 12
3011 Bern, Schweiz
eMail: ulrich.preuss@kjp.unibe.ch
